[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344795-105":59,"doc-detail-344795-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","head-and-neck-cancers-medical-costs-in-a-universal-health-system-a-population-based-case-control-study","Head and Neck Cancers Medical Costs in a Universal Health System - A Population-Based Case-Control Study","","Head and neck cancers (HNC) create a substantial economic burden for healthcare systems, especially when evaluating resource allocation in universal coverage settings. The study quantified direct medical costs over 60 months after diagnosis and assessed cost differences by cancer subsite, stage, and treatment modality. Using population-based matched case-control administrative data from Ontario, Canada, it included 19,832 adults diagnosed between 2007 and 2020. Costs peaked early after diagnosis and varied by stage and multimodal therapy needs.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/head-and-neck-cancers-medical-costs-in-a-universal-health-system-a-population-based-case-control-study/344795/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/head-and-neck-cancers-medical-costs-in-a-universal-health-system-a-population-based-case-control-study/344795.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of this population-based case-control study?","Question",{"text":112,"@type":113},"To quantify the direct medical costs of head and neck cancers over 60 months post-diagnosis and to evaluate how costs vary by cancer subsite, stage, and treatment modality.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants selected and how were controls matched?",{"text":117,"@type":113},"The study included 19,832 adults diagnosed with head and neck cancers between 2007 and 2020. Each case was matched with 5 non-cancer controls by age, sex, and comorbidity.",{"name":119,"@type":110,"acceptedAnswer":120},"When did healthcare costs peak, and how did they change over time?",{"text":121,"@type":113},"Costs peaked in the first 3 months after diagnosis and declined over time.",{"name":123,"@type":110,"acceptedAnswer":124},"Which cancers and treatments were associated with the highest costs?",{"text":125,"@type":113},"Larynx/hypopharynx cancers incurred the highest costs across most phases. Advanced-stage disease, especially stage IV, nearly doubled costs versus stage I, and multimodal therapy (notably surgery plus chemoradiation) produced the highest costs across all phases.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},344795,1790181750,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Head and Neck Cancers Medical Costs ina Universal Health System: A PopulationBased Case-Control Study  \nNoémie Villemure-Poliquin, MD, MSc, FRCSC 1 ,2,3, Rui Fu, PhD 1 ,2,4, Kelvin K. W. Chan, MD, MSc, PhD, FRCPC2,4,5, Qing Li, MMath4, Kennedy Ayoo, MD6, Frances Wright, MD, MEd, FRCSC2,3,4,5,6,7,8,9, 10, Irene Karam, MD, FRCPC 1 ,2,4, 10,  \nNatalie G. Coburn, MD, MPH, FRCSC 1 ,2,4,9, 10, Julie Hallet, MD, MSc, FRCSC 1 ,2,4,9, 10, and Antoine Eskander, MD, ScM, FRCSC 1 ,2,3  \nAbstract  \nJournal of Otolaryngology-Head & Neck Surgery  \nVolume 55: 1–11  \n© The Author(s) 2026  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/19160216251406521](DOI: 10.1177/19160216251406521)[ ](DOI: 10.1177/19160216251406521)[journals.sagepub.com/home/ohn](journals.sagepub.com/home/ohn)  \nImportance. Head and neck cancers (HNC) impose a significant economic burden on healthcare systems. Understanding the direct medical costs across different phases of care is crucial for resource allocation and cost-effectiveness evaluations, particularly in universal healthcare settings.  \nObjective. To quantify the direct medical costs of HNC over 60 months postdiagnosis and examine cost variations by cancer subsite, stage, and treatment modality.  \nDesign. Population-based, matched case–control study using administrative healthcare data.  \nSetting. Ontario, Canada, a province with a publicly funded universal healthcare system.  \nParticipants. We included 19,832 adults diagnosed with HNC between 2007 and 2020. Each case was matched with 5 noncancer controls based on age, sex, and comorbidity.  \nExposures. HNC diagnosis, categorized by cancer subsite, stage, and treatment modality.  \nMain Outcome Measures. Mean per-person direct medical costs attributable to HNC over a 63-month period, analyzed by phase of care, cancer subsite, stage, and treatment modality.  \nResults. The mean per-person cost attributable to HNC over 63months was $53,812.9 ±$762.2. Costs peaked in the first 3 months postdiagnosis ($9709.7 ±$36.1per month) and declined over time. Larynx/hypopharynx cancers incurred the highest costs across most phases. Advanced-stage cancers were associated with increased costs, with stage IV cancers nearly doubling the costs of stage I. Multimodal treatments, particularly surgery combined with chemoradiation, resulted in the highest costs across all phases (P \u003C .01).  \nConclusions. HNC results in substantial healthcare costs, with significant variations by subsite, stage, and treatment modality. The highest costs occur in the early treatment phase and remain elevated for patients requiring multimodal therapies.  \nRelevance. These findings provide critical data for policymakers and health system authorities to optimize resource allocation and assess cost-effectiveness. Future research should explore indirect costs and the impact of early detection strategies to reduce the economic burden of HNC.  \nLevel of evidence. 3  \nKeywords  \nhead and neck cancer, health care costs, survivorship  \nReceived March 5, 2025; accepted September 15, 2025.  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial  \n4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-access-at-sage](https://us.sagepub.com/en-us/nam/open-access-at-sage)).  \nGraphical Abstract  \n1 Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada 2ICES, Toronto, ON, Canada  \n3Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, ON, Canada 4Sunny","cbCaigeA9f3K83jV","https://ap.wps.com/l/cbCaigeA9f3K83jV","pdf",1272700,11,"English","# Importance\n# Objective\n# Design\n# Setting and Participants\n# Exposures and Outcome Measures\n# Results\n## Cost magnitude and trajectory\n## Differences by subsite, stage, and treatment\n# Conclusions and Relevance\n# Keywords","[{\"question\":\"What was the main goal of this population-based case-control study?\",\"answer\":\"To quantify the direct medical costs of head and neck cancers over 60 months post-diagnosis and to evaluate how costs vary by cancer subsite, stage, and treatment modality.\"},{\"question\":\"How were participants selected and how were controls matched?\",\"answer\":\"The study included 19,832 adults diagnosed with head and neck cancers between 2007 and 2020. Each case was matched with 5 non-cancer controls by age, sex, and comorbidity.\"},{\"question\":\"When did healthcare costs peak, and how did they change over time?\",\"answer\":\"Costs peaked in the first 3 months after diagnosis and declined over time.\"},{\"question\":\"Which cancers and treatments were associated with the highest costs?\",\"answer\":\"Larynx/hypopharynx cancers incurred the highest costs across most phases. Advanced-stage disease, especially stage IV, nearly doubled costs versus stage I, and multimodal therapy (notably surgery plus chemoradiation) produced the highest costs across all phases.\"}]","Head and Neck Cancers Medical Costs in a Universal Health System - A Population-Based Case-Control Study | PDF",1790055285,28,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4c44725b16ed22cc5ea7e1ab3bef2a0.webp",983,1272,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab167350d5f70851346ac561de40cb17.webp",982,1270,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef9b0f6b6d2e5b9f891c4f335584340b.webp",981,1269,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d798c94fed784911342d3d675eb445d.webp",980,1268]